A multisociety Delphi consensus statement on new fatty liver disease nomenclature

E. Rinella, Mary; V. Lazarus, Jeffrey; Ratziu, Vlad; M. Francque, Sven; J. Sanyal, Arun; Kanwal, Fasiha; Romero, Diana; F. Abdelmalek, Manal; M. Anstee, Quentin; Pablo Arab, Juan; Arrese, Marco; Bataller, Ramon; Beuers, Ulrich; Boursier, Jerome; Bugianesi, Elisabetta; D. Byrne, Christopher; E. Castro Narro, Graciela; Chowdhury, Abhijit; Cortez-Pinto, Helena; R. Cryer, Donna; Cusi, Kenneth; El-Kassas, Mohamed; Klein, Samuel; Eskridge, Wayne; Fan, Jiangao; Gawrieh, Samer; D. Guy, Cynthia; A. Harrison, Stephen; Up Kim, Seung; G. Koot, Bart; Korenjak, Marko; V. Kowdley, Kris; Lacaille, Florence; Loomba, Rohit; Mitchell-Thain, Robert; R. Morgan, Timothy; E. Powell, Elisabeth; Roden, Michael; Romero-Gómez, Manuel; Silva, Marcelo; Prasad Singh, Shivaram; C. Sookoian, Silvia; Wendy Spearman, C.; Tiniakos, Dina; Valenti, Luca; B. Vos, Miriam; Wai-Sun Wong, Vincent; Xanthakos, Stavra; Yilmaz, Yusuf; Younossi, Zobair; Hobbs, Ansley; Villota-Rivas, Marcela; N. Newsome, Philip; behalf of the NAFLD Nomenclature consensus group, on

doi:10.1097/hep.0000000000000520

Public

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Shared by NobleBlocks on Jun 24, 2023 • 12:00 AM UTC

Authors:

Mary E. Rinella

Jeffrey V. Lazarus

Vlad Ratziu

Abstract

The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to determine if content experts and patient advocates were in favor of a change in nomenclature and/or definition. A modified D...

Discussions